The identification and quantification of actionable mutations are critical for guiding targeted therapy and monitoring drug response in colorectal cancer. Liquid biopsy (LB) based on plasma cell-free DNA analysis has emerged as a non-invasive approach with many clinical advantages over conventional tissue sampling. Here, we developed a LB protocol using ultra-deep massive parallel sequencing and validated its clinical performance for detection and quantification of actionable mutations in three major driver genes (KRAS, NRAS and BRAF). The assay showed a 92% concordance for mutation detection between plasma and paired tissues and great reliability in quantification of variant allele frequency.
Epidemiology of hepatocellular carcinoma (HCC) showed a correlation between incidence and geographical-relevant risk factors. This study aims to compare the distributions of cancer stem cells (CSC) in two distant populations in Asia and Europe. We analyzed 52 and 43 selected HCC patients undergoing hepatectomy in Ho Chi Minh City (Vietnam) and Trieste (Italy). Each patient sample consisted of HCC, peri-HCC, and non-tumoral (distal) tissue. Demographic data were recorded together with clinical findings. The protocol for the collection of tissue samples and RNA was standardized in both laboratories and gene expression analysis was performed in a single laboratory with identical PCR conditions. Baseline data showed comparable laboratory findings between the two cohorts. mRNA distribution showed a comparable pattern of all CSC markers analyzed with the expression of CD90 progressively increasing from distal and peri-HCC to be highest in HCC (p < 0.001), confirmed by immunofluorescence data. CD90 mRNA distribution was related to HBV-related HCC and a tumor diameter less than 5 cm. Patients with high tumoral CD90 mRNA had a shorter time (p < 0.05) to tumor recurrence compared to patients with lower CD90. This comparative study showed that CD90 mRNA expressions are comparable between Eastern and Western HCC cases.
30 January 2018 in Scandinavian Journal of Clinical and Laboratory Investigation
Viral hepatitis infection is a major global issue and a leading cause of liver disease and associated deaths. Over time, patients infected with hepatitis B (HBV) or C virus (HCV) develop cirrhosis and, eventually, hepatocellular carcinoma (HCC). For this reason, they need to be constantly monitored. Current Asian guidelines recommend the determination of serum alpha-fetoprotein (AFP) together with liver ultrasounds every six months to detect HCC nodules. However, both methods have several limitations, and other biomarkers have been studied for monitoring cirrhosis, including SCCA-IgM, an immune-complex formed by Squamous Cell Carcinoma Antigen and IgM. To date, SCCA-IgM has been validated as a novel biomarker for liver diseases only in European populations. The aim of our study was to analyze SCCA-IgM as a biomarker to monitor cirrhosis evolution in an Asian cohort of patients and to compare its performance to that of AFP. We analyzed the concentration of AFP and SCCA-IgM in serum samples obtained from a group of Asian adult patients with cirrhosis or HCC and a control group of patients admitted for gastrointestinal disorders. In untreated patients and similarly to AFP, SCCA-IgM levels were significantly higher in patients with cirrhosis compared to those with HCC. In addition, SCCA-IgM, but not AFP serological levels, were significantly lower in HCC patients who were treated with surgical resection compared to those who received a different therapy.
Supplementary Table S1 summarizes RNA quality metrics for swab and tissue samples, sequencing quality statistics for swab samples (with and without bacterial rRNA depletion) as well as tissue samples, and gene detection profiles for paired samples, including counts of shared and tissue-specific genes across both global and OSCC-associated gene sets.
Supplementary Figure S4 - Gene expression concordance and overlap of HNSCC-Associated genes between swab and tissue samples. (A) Heatmap illustrates the Pearson correlation coefficients r of gene expression level, normalized to Transcript Per Million (TPM), across all samples, with color intensity representing the strength of correlation. (B) A Venn diagram shows the overlap of genes, with significant genes of HNSCC cancer in oncodb database, identified from both swab (n=39)(yellow) and tissue (n=39)(blue) samples.
Supplementary Figure S3 - Comparison of read mapping profiles and bacterial rRNA characterization in swab and tissue samples. (A) Stack bar plot illustrates the distribution of sequencing reads, showing the percentage of unmapped reads (red), uniquely mapped reads (green), and reads mapped to multiple sites (blue) to the human genome (hg38) from swab (without [No] (n=18) and with [Yes] (n=39) bacterial rRNA depletion) and tissue samples. (B) Mapping and OTU-picking read counts of non-depleted bacterial rRNA swabs (n=18) in Silva metatranscriptomic and metagenomic database.